ストックスクリーナーアプリを入手
1.36
2.86%
-0.04
アフターアワーズ：
1.35
-0.01
-0.74%
前日終値:
$1.40
開ける：
$1.4
24時間の取引高:
114.69K
Relative Volume:
0.26
時価総額：
$122.68M
収益：
-
当期純損益:
$-27.09M
株価収益率:
-3.3697
EPS:
-0.4036
ネットキャッシュフロー:
$-26.52M
1週間 パフォーマンス:
-3.55%
1か月 パフォーマンス:
+3.03%
6か月 パフォーマンス:
+7.94%
1年 パフォーマンス:
+8.80%
1日の値動き範囲:
$1.35
$1.40
1週間の範囲:
$1.31
$1.43
52週間の値動き範囲:
$0.9228
$1.92
Vivani Medical Inc Stock (VANI) Company Profile
Compare VANI vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.36 | 126.28M | 0 | -27.09M | -26.52M | -0.4036 |
VRTX
Vertex Pharmaceuticals Inc
|
515.57 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.86 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
986.80 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.94 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.66 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vivani Medical Inc (VANI) 最新ニュース
Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com Canada
Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached - TradingView
Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold" - MarketBeat
Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal - foreignpolicyjournal.com
Vivani Medical Fully Enrolls Phase 1 Semaglutide Implant Trial; Data Due November - Minichart
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Nigeria
Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Vivani Medical Q2 Results: EPS beats estimate, losses narrow 41% YoY - scanx.trade
Vivani Medical: Q2 Earnings Snapshot - AOL.com
Vivani Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
20 Participants Dosed in Semaglutide Trial; Data Due in November - Stock Titan
Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027 - Stock Titan
ClearOne (CLRO) details Cortigent reverse merger, 78% Vivani control and new equity plan - Stock Titan
ClearOne to merge with Cortigent, pivoting to neurotech under new Nasdaq ticker - Dealroom
Vivani Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
ClearOne Inc. (CLRO) majority holder cancels warrant as Cortigent merger proceeds - Stock Titan
Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com Nigeria
Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial - marketscreener.com
Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial - TipRanks
Form 8K Vivani Medical Inc For: 6 August - Investing.com India
Semaglutide implant trial doses all 20 participants; data expected in November - Stock Titan
ClearOne Cancels 437,500 First Finance Warrants at $5.00 Amid Cortigent Merger Process - TradingView
Vivani Medical (VANI) to Announce Earnings on Wednesday - MarketBeat
Enterprise value to EBITDA forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical, Inc. Revenue Breakdown – NASDAQ:VANI - TradingView
Form 4 Vivani Medical Inc For: 30 July By Investing.com - Investing.com Nigeria
Vivani Medical (VANI) awards CEO 200K stock options and 100K RSUs - Stock Titan
Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs - Stock Titan
Vivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO - Stock Titan
Form 4 Vivani Medical Inc For: 28 July By Investing.com - Investing.com Canada
Vivani Medical, Inc. (VANI) awards stock options in lieu of director fees - Stock Titan
Vivani Medical (VANI) Slides Nearly 8% as Shares Approach Key SupportCTA Positioning - dars.gov.et
Vivani Medical Market Sentiment - Benzinga España
Vivani Medical Inc. Revenue Breakdown – FWB:U5P - TradingView
Vivani Medical Inc (VANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - Bernama
Vivani Medical Inc (VANI) Cash Flow - TradingKey
Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivani Medical Inc (VANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Enterprise value to revenue forward of Vivani Medical Inc. – FWB:U5P - TradingView
Enterprise value to EBITDA forward of Vivani Medical Inc. – FWB:U5P - TradingView
ClearOne (CLRO) to acquire Cortigent, cede control to Vivani in stock deal - Stock Titan
Vivani Medical Highlights Upcoming SLIM-1 First Dosing Milestone - TipRanks
Form 4 Vivani Medical Inc For: 16 July By Investing.com - Investing.com Nigeria
Vivani Medical (NASDAQ: VANI) Targets August Human Trial For Semaglutide Implant Following Novo Nordisk Evaluation Deal - foreignpolicyjournal.com
New Form 4! Biggun at that! Hehehe - Moomoo
Vivani Medical director Gregg Williams buys $1m in stock - Investing.com UK
Vivani Medical director Gregg Williams buys $1m in stock By Investing.com - Investing.com Australia
Vivani Medical (NASDAQ: VANI) insider buys 793,650 shares at $1.26 - Stock Titan
Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentation - TradingView
Vivani Medical Inc (VANI) 財務データ
収益
当期純利益
現金流量
EPS
Vivani Medical Inc (VANI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Williams Gregg | Director |
Jun 15 '26 |
Buy |
1.26 |
1,587,301 |
1,999,999 |
36,119,086 |
| Williams Gregg | Director |
May 15 '26 |
Buy |
1.26 |
1,587,301 |
1,999,999 |
34,531,785 |
| Williams Gregg | Director |
Apr 15 '26 |
Buy |
1.26 |
1,587,301 |
1,999,999 |
32,944,484 |
| Williams Gregg | Director |
Mar 15 '26 |
Buy |
1.07 |
1,575,231 |
1,683,335 |
31,357,183 |
| Williams Gregg | Director |
Feb 15 '26 |
Buy |
1.06 |
1,866,492 |
1,983,333 |
29,781,952 |
| Williams Gregg | Director |
Jan 27 '26 |
Buy |
1.48 |
1,351,351 |
1,999,999 |
27,915,460 |
| Williams Gregg | Director |
Jan 15 '26 |
Buy |
1.14 |
1,737,765 |
1,983,334 |
26,564,109 |
| Mendelsohn Aaron | Director |
Dec 29 '25 |
Buy |
1.23 |
20,000 |
24,600 |
188,170 |
| Williams Gregg | Director |
Dec 15 '25 |
Buy |
1.14 |
1,737,765 |
1,983,334 |
24,826,344 |
| Williams Gregg | Director |
Nov 15 '25 |
Buy |
1.14 |
1,737,764 |
1,983,333 |
23,088,579 |
2.67%
0.04%
大文字化:
|
ボリューム (24 時間):